When put on 254 patients with stage III or II disease diagnosed by scientific examination.
All privileges reserved. Neither of these ongoing parties endorse or suggest any commercial products, services, or equipment.. When put on 254 patients with stage III or II disease diagnosed by scientific examination, magnetic resonance imaging, or ultrasound, 18FDG-PET-CT results led to a modification of American Joint Committee on Cancers stage in 30. 18FDG-PET-CT had the greatest impact on sufferers with the most advanced disease, leading to a stage change in 16.1 percent of stage IIB individuals, 31.7 percent of stage IIIA patients, 51.4 percent of stage IIIB individuals, and 47.1 percent of stage IIIC individuals. Related StoriesMD Anderson research reveals why chemotherapy drugs not effective for many pancreatic cancers patientsNew RNA test of blood platelets can be used to detect area of cancerNew results reveal association between colorectal cancers and melanoma drug treatment’It is hoped that the info provided at preliminary staging might lead to better management of these patients who account for the biggest mortality rate from breasts cancer,’ say Groheux et al. (more…)